L. TALAN Et Al. , "A1151 Rifampicin combination therapies for the treatment of ICU infections due to colistin resistant acinetobacter spp," Milano, İtalya’da ESICM 29. Yıllık Kongresi , Milan, Italy, 2016
TALAN, L. Et Al. 2016. A1151 Rifampicin combination therapies for the treatment of ICU infections due to colistin resistant acinetobacter spp. Milano, İtalya’da ESICM 29. Yıllık Kongresi , (Milan, Italy).
TALAN, L., YILMAZ, G., GÜVEN, G., YÖRÜK, F., & ALTINTAŞ, N. D., (2016). A1151 Rifampicin combination therapies for the treatment of ICU infections due to colistin resistant acinetobacter spp . Milano, İtalya’da ESICM 29. Yıllık Kongresi, Milan, Italy
TALAN, LEYLA Et Al. "A1151 Rifampicin combination therapies for the treatment of ICU infections due to colistin resistant acinetobacter spp," Milano, İtalya’da ESICM 29. Yıllık Kongresi, Milan, Italy, 2016
TALAN, LEYLA Et Al. "A1151 Rifampicin combination therapies for the treatment of ICU infections due to colistin resistant acinetobacter spp." Milano, İtalya’da ESICM 29. Yıllık Kongresi , Milan, Italy, 2016
TALAN, L. Et Al. (2016) . "A1151 Rifampicin combination therapies for the treatment of ICU infections due to colistin resistant acinetobacter spp." Milano, İtalya’da ESICM 29. Yıllık Kongresi , Milan, Italy.
@conferencepaper{conferencepaper, author={LEYLA FERLİÇOLAK Et Al. }, title={A1151 Rifampicin combination therapies for the treatment of ICU infections due to colistin resistant acinetobacter spp}, congress name={Milano, İtalya’da ESICM 29. Yıllık Kongresi}, city={Milan}, country={Italy}, year={2016}}